Clinical Trial Update: Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating sequential fluoxetine use for smokers with elevated depressive symptoms; study completed with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Butler Hospital | Conditions: Major Depressive Disorder, Nicotine Dependence | Phase 3 | Status: COMPLETED | Results posted: 2018-10-16